Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
Background: Renal interstitial fibrosis is characterized by the accumulation of extracellular matrix proteins, which is a common feature of chronic kidney diseases. Summary: Increasing evidence has shown the aberrant expression of histone deacetylases (HDACs) in the development and progression of re...
Main Authors: | Ling Nie, Yong Liu, Bo Zhang, Jinghong Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2020-03-01
|
Series: | Kidney Diseases |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/505295 |
Similar Items
-
Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01) -
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01) -
Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01) -
Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01) -
Histone Deacetylase 11 Contributes to Renal Fibrosis by Repressing KLF15 Transcription
by: Lei Mao, et al.
Published: (2020-04-01)